Dr. Ayed Ayed, M.D.
What this data tells you about Dr. Ayed
Dr. Ayed Ayed is a hematology & oncology in Jacksonville, FL, with 13 years in practice. Based on federal Medicare data, Dr. Ayed performed 30,225 Medicare services across 1,173 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ayed received a total of $51,900 from 53 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ayed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 21,750 | $1 | $4 |
| Contrast dye for imaging (iodine-based) | 2,300 | $0 | $1 |
| Dexamethasone injection (steroid) | 1,066 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,020 | $18 | $40 |
| Injection, granisetron hydrochloride, 100 mcg | 760 | $0 | $41 |
| Blood draw (venipuncture) | 700 | $8 | $18 |
| Complete blood count (CBC) with differential | 570 | $8 | $41 |
| Anti-nausea injection (Aloxi/palonosetron) | 460 | $1 | $75 |
| Office visit, established patient (30-39 min) | 349 | $93 | $162 |
| Administration of chemotherapy into vein, 1 hour or less | 229 | $96 | $355 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 185 | $21 | $90 |
| Hospital follow-up visit, moderate complexity | 111 | $63 | $115 |
| Drug injection, under skin or into muscle | 82 | $11 | $42 |
| Injection of additional new drug or substance into vein | 80 | $10 | $55 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 75 | $46 | $160 |
| Administration of chemotherapy into vein, each additional hour | 56 | $22 | $80 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 51 | $70 | $70 |
| New patient office visit (45-59 min) | 44 | $122 | $265 |
| Administration of additional new drug or substance into vein, 1 hour or less | 43 | $43 | $175 |
| Initial hospital admission, high complexity | 38 | $137 | $330 |
| Infusion into a vein for hydration, each additional hour | 34 | $10 | $40 |
| Office visit, established patient, complex (40-54 min) | 33 | $133 | $235 |
| Injection, diphenhydramine hcl, up to 50 mg | 32 | $1 | $4 |
| Ct scan of chest with contrast | 21 | $43 | $500 |
| Infusion, normal saline solution , 1000 cc | 21 | $2 | $97 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | $401 | $1,000 |
| CT scan of abdomen and pelvis with contrast | 19 | $160 | $535 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 17 | $1,098 | $2,400 |
| Infusion into a vein for hydration, 31-60 minutes | 17 | $25 | $130 |
| Initial hospital admission, moderate complexity | 15 | $103 | $225 |
| Blood creatinine level | 14 | $5 | $29 |
| Office visit, established patient (20-29 min) | 13 | $55 | $104 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ayed is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and high industry engagement (consulting-driven, top 14%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ayed experienced with iron infusion (injectafer)?
Does Dr. Ayed receive payments from pharmaceutical companies?
How do Dr. Ayed's costs compare to other hematology & oncologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology